about
Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemicUpdate on HIV in Western EuropeAntiretroviral therapy for prevention of HIV transmission: implications for EuropeCost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settingsUse of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapyEstimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data.Potential future impact of a partially effective HIV vaccine in a southern African setting.Projected Lifetime Healthcare Costs Associated with HIV Infection.A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation ModelEffectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis.Sustainable HIV treatment in Africa through viral-load-informed differentiated care.Life expectancy living with HIV: recent estimates and future implications.Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM.Projected life expectancy of people with HIV according to timing of diagnosis
P50
Q21133704-BC9DC3C0-7001-4031-964A-20B06F2E030EQ26853700-8555C2F6-E76D-4AAA-9B21-9FD91B8A569CQ27023464-187FDC7B-D721-4E29-AA00-6104F890A307Q28543578-4EFC779C-3BBB-4407-8B45-F13FAB770AB1Q30000634-8BEF6C2E-574C-4728-BD99-EAAC2FD15B8DQ30982952-4C67230C-C02C-4168-A47F-60BEEEDA93D9Q34160133-BDFAF3E0-78BE-49B2-9CC4-E604BA0196CAQ35526724-50BD4235-D639-480F-A135-BA758B89CF41Q36523426-7E935C53-04E6-49A5-837A-F98661AAD196Q36769221-E925E630-227D-497B-9A5B-BC5AFB45D197Q37064741-EEE75000-140B-4040-921B-AA9EC1049654Q38065781-0ED4EC7D-2BFA-4E01-9C46-6F8FC6585DB4Q38435970-3AB9D230-5369-45CF-A540-A6D177449D0FQ38963785-93802116-4EB7-4696-BFEB-AAC9EE6C3600Q57476832-B52D9DD0-A8E4-42B4-9C98-AB5DDFD65CC4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fumiyo Nakagawa
@ast
Fumiyo Nakagawa
@en
Fumiyo Nakagawa
@es
Fumiyo Nakagawa
@nl
type
label
Fumiyo Nakagawa
@ast
Fumiyo Nakagawa
@en
Fumiyo Nakagawa
@es
Fumiyo Nakagawa
@nl
prefLabel
Fumiyo Nakagawa
@ast
Fumiyo Nakagawa
@en
Fumiyo Nakagawa
@es
Fumiyo Nakagawa
@nl
P106
P31
P496
0000-0002-6646-8744